SCHEMBL31009985

SCHEMBL31009985

CCOC(=O)CCSc1nc(Br)c(F)cc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 1/20 0.48
BRCA1 P38398 1/20 0.48
IDO1 P14902 1/20 0.48
ALDH1A1 P00352 7/20 0.46
HPGD P15428 6/20 0.46
GAA P10253 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 4/20 0.44
GLA P06280 1/20 0.44
POLB P06746 2/20 0.43
MAPK1 P28482 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31010032 0.86 HPGD (0.50) KMT2AMEN1BRCA1IDO1ALDH1A1
SCHEMBL20804137 0.69 L3MBTL1 (0.61) KMT2AMEN1BRCA1ALDH1A1HPGD
SCHEMBL16069693 0.68 SMN1; SMN2 (0.40) KMT2AMEN1ALDH1A1GAAKDM4E
SCHEMBL16334494 0.68 CYP1A2 (0.42) IDO1HPGDL3MBTL1MAPTSMN1; SMN2
SCHEMBL17045823 0.68 LMNA (0.42) KMT2AMEN1BRCA1IDO1ALDH1A1
SCHEMBL25270599 0.67 MAPT (0.55) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL7651344 0.67 HSP90AA1 (0.51) KMT2AMEN1ALDH1A1HPGDL3MBTL1
SCHEMBL26830072 0.67 KMT2A (0.49) KMT2AMEN1BRCA1ALDH1A1HPGD
SCHEMBL16334121 0.67 CYP1A2 (0.41) IDO1ALDH1A1HPGDL3MBTL1MAPT
SCHEMBL5450459 0.66 MAPT (0.47) KMT2AMEN1ALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648763-A2 COMPOUNDS FOR FGFRS INHIBITORS Cogent Biosciences, Inc. (US) 2025-11-19 EP disclosed
WO-2024151638-A2 COMPOUNDS FOR FGFRS INHIBITORS COGENT BIOSCIENCES, INC. (US) 2024-07-18 WO disclosed